Friday, May 28, 2021

Bajaj Healthcare launches drug to treat black fungus infection in COVID-19 patients

Bajaj Healthcare launches drug to treat black fungus infection in COVID-19 patients The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/34pXZ7Y
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...